Tech Company Financing Transactions
Extinction Pharmaceuticals Funding Round
CIT GAP Fund participated in a $50 thousand capital raise for Extinction Pharmaceuticals. The round was announced on 3/31/2011.
Transaction Overview
Company Name
Announced On
3/31/2011
Transaction Type
Venture Equity
Amount
$50,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
124 Country Club Dr.
Williamsburg, VA 23188
USA
Williamsburg, VA 23188
USA
Phone
Undisclosed
Email Address
Overview
Extinction Pharmaceuticals, Inc. is a drug development company with a proprietary and revolutionary therapeutic approach (i.e., administering D-cycloserine in conjunction with therapy) for treating anxiety disorders and other afflictions that can benefit from traditional talk therapy treatments.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Founder
Michael Davis
Founder
Jason McDevitt
Founder
Kerry Ressler
Browse more venture capital transactions:
Prev: 3/31/2011: Allocade venture capital transaction
Next: 3/31/2011: MedSynergies venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document all VC transactions involving tech companies. All VC database entries reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs